Episode

Pregabalin (Lyrica)

Podcast: PsychRounds: The Psychiatry Podcast
Published: Sep 24, 2025
Duration seconds: 860
Processing state: not_requested
Canonical source: https://podcasters.spotify.com/pod/show/psychrounds/episodes/Pregabalin-Lyrica-e37ng97
Audio: https://anchor.fm/s/eb936048/podcast/play/107773671/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2025-8-3%2F33021a81-8bca-df91-f250-426e23f43393.mp3
JSON: /v1/public/podcasts/psychrounds-the-psychiatry-podcast-6714703/episodes/pregabalin-lyrica
Markdown: /podcast/psychrounds-the-psychiatry-podcast-6714703/pregabalin-lyrica.md

Actions

POST https://stenobird.com/v1/public/podcasts/psychrounds-the-psychiatry-podcast-6714703/episodes/pregabalin-lyrica/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/psychrounds-the-psychiatry-podcast-6714703/pregabalin-lyrica.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Welcome back! Today, we will be talking about Pregabalin, brand-name Lyrica, a similar medication to Gabapentin, and we will specifically be focusing on its use in psychiatry. What are its benefits and drawbacks compared to Gabapentin? Sources: - https://pubmed.ncbi.nlm.nih.gov/33563173/ - https://pubmed.ncbi.nlm.nih.gov/39989902/ - https://pmc.ncbi.nlm.nih.gov/articles/PMC3699256/ - https://pubmed.ncbi.nlm.nih.gov/33563173/